[
  {
    "ts": "2025-12-11T05:08:28+00:00",
    "headline": "How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating",
    "summary": "Pfizer's latest narrative update leaves its fair value estimate steady at about $29.08 per share, even as analysts fine tune assumptions around the company’s long term trajectory. Slightly softer expectations for revenue growth are set against a more supportive backdrop for U.S. drug pricing and renewed interest in large cap biopharma, helping to stabilize the valuation case. As these shifts play out alongside evolving views on Pfizer’s pipeline and deal making, investors can follow the...",
    "url": "https://finance.yahoo.com/news/narrative-surrounding-pfizer-changing-obesity-050828048.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "dfa4cf20-3643-38c6-9153-9998f205a1b6",
      "content": {
        "id": "dfa4cf20-3643-38c6-9153-9998f205a1b6",
        "contentType": "STORY",
        "title": "How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating",
        "description": "",
        "summary": "Pfizer's latest narrative update leaves its fair value estimate steady at about $29.08 per share, even as analysts fine tune assumptions around the company’s long term trajectory. Slightly softer expectations for revenue growth are set against a more supportive backdrop for U.S. drug pricing and renewed interest in large cap biopharma, helping to stabilize the valuation case. As these shifts play out alongside evolving views on Pfizer’s pipeline and deal making, investors can follow the...",
        "pubDate": "2025-12-11T05:08:28Z",
        "displayTime": "2025-12-11T05:08:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/narrative-surrounding-pfizer-changing-obesity-050828048.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/narrative-surrounding-pfizer-changing-obesity-050828048.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]